Product Information
CARBAMAZEPINE 200 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1186 per EA under NDC 75834022101. Its NADAC has been published 303 times since Sep 9, 2020.
Strength
200 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834022101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA207798On Market Since
4/21/2020
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 200 MG TABLET has been published 303 times since Sep 9, 2020, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1186 per EA |
|---|---|
| All-time high | $0.3113 (Sep 16, 2020) |
| All-time low | $0.1005 (Jul 17, 2024) |
| 52-week high | $0.1285 |
| 52-week low | $0.1157 |
| Median price | $0.1582 |
| Average price | $0.1783 |
| Largest weekly change | +96.7% (Aug 28, 2024) |
| Weeks tracked | 303 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 200 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1186 per EA (NDC 75834022101), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 200 MG TABLET has declined 61.9%. It has been tracked across 303 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 200 MG TABLET?
Since Sep 9, 2020, the NADAC for CARBAMAZEPINE 200 MG TABLET has ranged from a low of $0.1005 (Jul 17, 2024) to a high of $0.3113 (Sep 16, 2020), with a median of $0.1582 per EA.
Are there cheaper alternatives to CARBAMAZEPINE 200 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as CARBAMAZEPINE 200 MG TABLET, but none are currently priced below it.
Who manufactures CARBAMAZEPINE 200 MG TABLET?
CARBAMAZEPINE 200 MG TABLET (NDC 75834022101) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification